Adaptaquin
CAY-19720-5 5 mg
Data Sheet: 
SDS:
SDS:
CAS
385786-48-1
Formulation
A crystalline solid
Purity
≥95%
MW
377,8
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An inhibitor of HIF-PH2 (IC50 = 2 micromolar); stabilizes HIF-1α protein and induces expression of EPO and VEGF in SH-SY5Y human neuroblastoma cells; protects against glutathione depletion-induced cell death in rat primary cortical neurons (IC50 = 0.25 μM); reduces glutamate-induced cell death in HT-22 cells; increases pellet retrieval in the single-pellet reaching task in a a rat autologous striatal blood infusion model of intracerebral hemmorhage and normalizes preference for ipsilateral turns in a mouse model of striatal hemorrhage at 30 mg/kg
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
